These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 37149931)

  • 21. Effectiveness of BNT162b2 vaccine against SARS-CoV-2 Delta and Omicron infection in adolescents, Norway, August 2021 to January 2022.
    Veneti L; Berild JD; Watle SV; Starrfelt J; Greve-Isdahl M; Langlete P; Bøås H; Bragstad K; Hungnes O; Meijerink H
    Int J Infect Dis; 2023 May; 130():182-188. PubMed ID: 36893942
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Major Update 2: Antibody Response and Risk for Reinfection After SARS-CoV-2 Infection-Final Update of a Living, Rapid Review.
    Holmer HK; Mackey K; Fiordalisi CV; Helfand M
    Ann Intern Med; 2023 Jan; 176(1):85-91. PubMed ID: 36442059
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of symptoms, comorbidities, and reinfections in individuals infected with Wild-Type SARS-CoV-2, Delta, or Omicron variants: a comparative study in western Mexico.
    Peña Rodríguez M; Hernández Bello J; Vega Magaña N; Viera Segura O; García Chagollán M; Ceja Gálvez HR; Mora Mora JC; Rentería Flores FI; García González OP; Muñoz Valle JF
    Front Public Health; 2023; 11():1149795. PubMed ID: 37181688
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Robust humoral and cellular immune responses and low risk for reinfection at least 8 months following asymptomatic to mild COVID-19.
    Havervall S; Ng H; Jernbom Falk A; Greilert-Norin N; Månberg A; Marking U; Laurén I; Gabrielsson L; Salomonsson AC; Aguilera K; Kihlgren M; Månsson M; Rosell A; Hellström C; Andersson E; Olofsson J; Skoglund L; Yousef J; Pin E; Lord M; Åberg M; Hedhammar M; Tegel H; Dönnes P; Phillipson M; Nilsson P; Klingström J; Mangsbo S; Hober S; Thålin C
    J Intern Med; 2022 Jan; 291(1):72-80. PubMed ID: 34459525
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlates of protection against COVID-19 infection and intensity of symptomatic disease in vaccinated individuals exposed to SARS-CoV-2 in households in Israel (ICoFS): a prospective cohort study.
    Regev-Yochay G; Lustig Y; Joseph G; Gilboa M; Barda N; Gens I; Indenbaum V; Halpern O; Katz-Likvornik S; Levin T; Kanaaneh Y; Asraf K; Amit S; Rubin C; Ziv A; Koren R; Mandelboim M; Tokayer NH; Meltzer L; Doolman R; Mendelson E; Alroy-Preis S; Kreiss Y
    Lancet Microbe; 2023 May; 4(5):e309-e318. PubMed ID: 36963419
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Omicron infection increases IgG binding to spike protein of predecessor variants.
    Mahalingam G; Periyasami Y; Arjunan P; Subaschandrabose RK; Mathivanan TV; Mathew RS; Devi RKT; Premkumar PS; Muliyil J; Srivastava A; Moorthy M; Marepally S
    J Med Virol; 2023 Feb; 95(2):e28419. PubMed ID: 36546401
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factors Associated With Protection From SARS-CoV-2 Omicron Variant Infection and Disease Among Vaccinated Health Care Workers in Israel.
    Gilboa M; Gonen T; Barda N; Cohn S; Indenbaum V; Weiss-Ottolenghi Y; Amit S; Asraf K; Joseph G; Levin T; Kanaaneh Y; Aydenzon A; Canetti M; Freedman L; Zuckerman N; Mendelson E; Doolman R; Kreiss Y; Regev-Yochay G; Lustig Y
    JAMA Netw Open; 2023 May; 6(5):e2314757. PubMed ID: 37219906
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SARS CoV-2 reinfection rate is higher in the Omicron variant than in the Alpha and Delta variants.
    Özüdoğru O; Bahçe YG; Acer Ö
    Ir J Med Sci; 2023 Apr; 192(2):751-756. PubMed ID: 35711013
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Post-Covid-19 condition (Long Covid) in children and young people 12 months after infection or reinfection with the Omicron variant: a prospective observational study.
    Pinto Pereira SM; Nugawela MD; Stephenson T; Foret-Bruno P; Dalrymple E; Xu L; Whittaker E; Heyman I; Ford T; Segal T; Chalder T; Ladhani SN; Mensah AA; McOwat K; Simmons R; ; Shafran R
    Sci Rep; 2024 Apr; 14(1):9957. PubMed ID: 38693285
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between SARS-CoV-2 variants and post COVID-19 condition: findings from a longitudinal cohort study in the Belgian adult population.
    Thi Khanh HN; Cornelissen L; Castanares-Zapatero D; De Pauw R; Van Cauteren D; Demarest S; Drieskens S; Devleesschauwer B; De Ridder K; Charafeddine R; Smith P
    BMC Infect Dis; 2023 Nov; 23(1):774. PubMed ID: 37940843
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants.
    Accorsi EK; Britton A; Fleming-Dutra KE; Smith ZR; Shang N; Derado G; Miller J; Schrag SJ; Verani JR
    JAMA; 2022 Feb; 327(7):639-651. PubMed ID: 35060999
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neutralisation sensitivity of the SARS-CoV-2 omicron (B.1.1.529) variant: a cross-sectional study.
    Sheward DJ; Kim C; Ehling RA; Pankow A; Castro Dopico X; Dyrdak R; Martin DP; Reddy ST; Dillner J; Karlsson Hedestam GB; Albert J; Murrell B
    Lancet Infect Dis; 2022 Jun; 22(6):813-820. PubMed ID: 35305699
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vaccine effectiveness against SARS-CoV-2 infection or COVID-19 hospitalization with the Alpha, Delta, or Omicron SARS-CoV-2 variant: A nationwide Danish cohort study.
    Gram MA; Emborg HD; Schelde AB; Friis NU; Nielsen KF; Moustsen-Helms IR; Legarth R; Lam JUH; Chaine M; Malik AZ; Rasmussen M; Fonager J; Sieber RN; Stegger M; Ethelberg S; Valentiner-Branth P; Hansen CH
    PLoS Med; 2022 Sep; 19(9):e1003992. PubMed ID: 36048766
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long COVID and Hybrid Immunity among Children and Adolescents Post-Delta Variant Infection in Thailand.
    Jarupan M; Jantarabenjakul W; Jaruampornpan P; Subchartanan J; Phasomsap C; Sritammasiri T; Cartledge S; Suchartlikitwong P; Anugulruengkitt S; Kawichai S; Puthanakit T
    Vaccines (Basel); 2023 Apr; 11(5):. PubMed ID: 37242988
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long COVID symptoms in exposed and infected children, adolescents and their parents one year after SARS-CoV-2 infection: A prospective observational cohort study.
    Haddad A; Janda A; Renk H; Stich M; Frieh P; Kaier K; Lohrmann F; Nieters A; Willems A; Huzly D; Dulovic A; Schneiderhan-Marra N; Jacobsen EM; Fabricius D; Zernickel M; Stamminger T; Bode SFN; Himpel T; Remppis J; Engel C; Peter A; Ganzenmueller T; Hoffmann GF; Haase B; Kräusslich HG; Müller B; Franz AR; Debatin KM; Tönshoff B; Henneke P; Elling R
    EBioMedicine; 2022 Oct; 84():104245. PubMed ID: 36155957
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Observed protection against SARS-CoV-2 reinfection following a primary infection: A Danish cohort study among unvaccinated using two years of nationwide PCR-test data.
    Michlmayr D; Hansen CH; Gubbels SM; Valentiner-Branth P; Bager P; Obel N; Drewes B; Møller CH; Møller FT; Legarth R; Mølbak K; Ethelberg S
    Lancet Reg Health Eur; 2022 Sep; 20():100452. PubMed ID: 35791335
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early Omicron infection is associated with increased reinfection risk in older adults in long-term care and retirement facilities.
    Breznik JA; Rahim A; Zhang A; Ang J; Stacey HD; Bhakta H; Clare R; Liu LM; Kennedy A; Hagerman M; Kajaks T; Miller MS; Nazy I; Bramson JL; Costa AP; Bowdish DME
    EClinicalMedicine; 2023 Sep; 63():102148. PubMed ID: 37753447
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum Fc-Mediated Monocyte Phagocytosis Activity Is Stable for Several Months after SARS-CoV-2 Asymptomatic and Mildly Symptomatic Infection.
    Vangeti S; Periasamy S; Sun P; Balinsky CA; Mahajan AS; Kuzmina NA; Soares-Schanoski A; Cooper E; Beckett C; Marayag J; Marrone A; Nunez E; Ge Y; Porter CK; Goforth CW; Lizewski SE; Lizewski R; Jani V; Sugiharto VA; Schilling M; Yu XB; Marjanovic N; George MC; Bukreyev A; Sealfon SC; Letizia AG; Ramos I
    Microbiol Spectr; 2022 Dec; 10(6):e0183722. PubMed ID: 36374040
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical manifestations and long-term symptoms associated with SARS-CoV-2 omicron infection in children aged 0-17 years in Beijing: a single-center study.
    Li J; Li J; Cao L; Wang L; Chen X; Niu W; Dang L; Dai S; Wang Y; Ge M; Liu W; Song Q; Xu W; Ma L
    Front Pediatr; 2024; 12():1332020. PubMed ID: 38813546
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical Presentation of COVID-19 and Antibody Responses in Bangladeshi Patients Infected with the Delta or Omicron Variants of SARS-CoV-2.
    Ghosh AK; Landt O; Yeasmin M; Sharif M; Ratul RH; Molla MA; Nafisa T; Mosaddeque MB; Hosen N; Bulbul MRH; Mamunur R; Islam A; Shakil SS; Kaiser M; Amin MR; Lytton SD
    Vaccines (Basel); 2022 Nov; 10(11):. PubMed ID: 36423054
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.